Exec VP-U.S. Operations Joseph Smith to president. Stanley Rosenbaum to VP-controller; Robert Beckman to VP & general manager, biochemicals and diagnostics; H. Charles Ford to VP-personnel; F. Lee Berg to VP-sales & marketing, ethical products; and John Fiedler to VP-Fort Washington operations. "The Pink Sheet" incorrectly listed the latter five appointments as occurring at Rorer, rather than in the U.S. division ("The Pink Sheet" April 14, In Brief).
You may also be interested in...
In what could be a blow to some aspiring developers eyeing the nascent but growing biosimilars market in China, new rules lay out when extrapolation of approved indications of reference biologics will be allowed, meaning this will not be automatic.
Without the MRA that allows unimpeded bilateral device trade between the EU and Switzerland, Swiss industry is having to find ways of limiting the damage that newly erected barriers will cause after the MDR comes into force.
Amneal is set to benefit from 180 days of US exclusivity for its norelgestromin and ethinyl estradiol contraceptive patch product after receiving FDA approval with a competitive generic therapy designation. The generic will be the only competitor to Mylan’s Xulane version.